OTC Healthcare in Bolivia
Euromonitor International's OTC Healthcare in Bolivia market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Get immediate access to strategic market analysis when you buy reports online
Tables: 72 | Publication date: Sep 2007
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouthcare; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
INTI SA Keeps Market Leadership
The Bolivian company INTI SA maintains leadership in the domestic pharmaceutical market. Although most of the company earnings come from Rx products, its OTC line increases each year, helping the company not only with volume growth but also value growth and its use of installed production capacity.
Despite the strong competition from imported products as well as contraband and illegal OTC remedies, INTI managed to grow and fortify its overall pharmaceutical market position in Bolivia (including Rx products) over the review period. However, the company is ranked third within the OTC market in Bolivia.
Traditional Medicine Maintains Its Strong Position
It is estimated that approximately 60% of the Bolivian population does not have access to medicines or medical treatment; due to this situation and also because "kallawaya" (traditional medicine) is accepted and practiced widely in Bolivia, herbal and natural medicines are very much accepted in the domestic market.
According to the Health Ministry in Bolivia, more than half of the Bolivian population practices or has been treated at least once by traditional medicine.
Acknowledging the importance of kallawaya medicine the government installed a Vice Ministry of Traditional Medicine as a new arm of the Health and Welfare Ministry, also creating special tests and registration for traditional medicines. All the medicines registered as natural and traditional are considered OTC. There are now 128 products registered.
Five Companies Control 50% of the Bolivian Pharmaceutical Market
There are five important companies in the pharmaceutical market in Bolivia with the biggest market shares. In general this is a concentrated market for Rx products, but a very fragmented one for OTC: INTI, South American Express, Bagó, Recalcine and Tecnofarma are the most important market suppliers, but, considering that Recalcine and Tecnofarma do not have strong OTC lines, it is safe to say the OTC market is a rather fragmented. There is no formal information on OTC shares, therefore whilst the five companies listed dominate the pharmaceutical market, this is not necessarily true of OTC.
Companies like Laboratorios Vita (a national company with no links with Vita Life Science) and INTI have very strong OTC lines and rather weak Rx lines, offering also a wide cosmetic line. Laboratorios Alcos SA, Laboratorios Sigma Corp and other small companies are other important players on the OTC domestic market.
Indigestion and Heartburn Remedies Are the Most Popular
Bolivian health law only authorises the sale of medicines and remedies through registered pharmacies and drugstores, although this law is not always respected since some products are sold in open markets, grocery stores and others.
Indigestion OTC products are the most widely distributed products in Bolivia, since the diet is rather unhealthy (greasy and spicy) any Bolivians can find a Digestan, an Alikal or the much more common remedy of herbal tea, in almost every store, vendor and even restaurant, as well as in every pharmacy or drugstore.
Table of contents
OTC HEALTHCARE IN BOLIVIA : MARKET INSIGHT
EXECUTIVE SUMMARY
INTI SA Keeps Market Leadership
Traditional Medicine Maintains Its Strong Position
Five Companies Control 50% of the Bolivian Pharmaceutical Market
Indigestion and Heartburn Remedies Are the Most Popular
KEY TRENDS AND DEVELOPMENTS
Distribution Is an Issue for OTC Healthcare
International Trade Agreements Cause Difficulties for National Companies
Contraband Is Still the Biggest Competitor
Pharmacy Chains Are Starting to Expand
MARKET INDICATORS
Table 1 Life Expectancy at Birth 2001-2006
MARKET DATA
Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006
Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
Table 4 OTC Healthcare Company Shares by Retail Value 2002-2006
Table 5 OTC Healthcare Brand Shares by Retail Value 2003-2006
Table 6 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
Table 7 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
Table 8 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
Table 9 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
APPENDIX
OTC Registration and Classification
Packaging and Labelling
Distribution
De-listing or De-reimbursement
Traditional Remedies
Homeopathy
Vitamins and Dietary Supplements Registration and Classification
Generics
Consumer Expenditure on Health Goods and Medical Services
Table 10 Consumer Expenditure on Health Goods and Medical Services 2001-2006
DEFINITIONS
Sources
Summary 1 Research Sources
ANALGESICS
Headlines
Trends
Competitive Landscape
Prospects
Sector Data
Table 11 Sales of Analgesics by Subsector: Value 2001-2006
Table 12 Sales of Analgesics by Subsector: % Value Growth 2001-2006
Table 13 Herbal vs Standard Topical Analgesics 2001/2006
Table 14 Analgesics Company Shares by Retail Value 2002-2006
Table 15 Analgesics Brand Shares by Retail Value 2003-2006
Table 16 Forecast Sales of Analgesics by Subsector: Value 2006-2011
Table 17 Forecast Sales of Analgesics by Subsector: % Value Growth 2006-2011
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES
Headlines
Trends
Competitive Landscape
Prospects
Sector Data
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2001-2006
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2001-2006
Table 20 Sales of Decongestants by Type: Value 2001-2006
Table 21 Sales of Decongestants by Type: % Value Growth 2001-2006
Table 22 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2001/2006
Table 23 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Retail Value 2002-2006
Table 24 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Retail Value 2003-2006
Table 25 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2006-2011
Table 26 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2006-2011
DIGESTIVE REMEDIES
Headlines
Trends
Competitive Landscape
Prospects
Sector Data
Table 27 Sales of Digestive Remedies by Subsector: Value 2001-2006
Table 28 Sales of Digestive Remedies by Subsector: % Value Growth 2001-2006
Table 29 Herbal vs Standard Digestive Remedies 2001/2006
Table 30 Digestive Remedies Company Shares by Retail Value 2002-2006
Table 31 Digestive Remedies Brand Shares by Retail Value 2003-2006
Table 32 Forecast Sales of Digestive Remedies by Subsector: Value 2006-2011
Table 33 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2006-2011
MEDICATED SKIN CARE
Headlines
Trends
Competitive Landscape
Prospects
Sector Data
Table 34 Sales of Medicated Skin Care by Subsector: Value 2001-2006
Table 35 Sales of Medicated Skin Care by Subsector: % Value Growth 2001-2006
Table 36 Herbal vs Standard Medicated Skin Care 2001/2006
Table 37 Medicated Skin Care Company Shares by Retail Value 2002-2006
Table 38 Medicated Skin Care Brand Shares by Retail Value 2003-2006
Table 39 Hair Loss Treatments Brand Shares by Retail Value 2003-2006
Table 40 Forecast Sales of Medicated Skin Care by Subsector: Value 2006-2011
Table 41 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2006-2011
VITAMINS AND DIETARY SUPPLEMENTS
Headlines
Trends
Competitive Landscape
Prospects
Sector Data
Table 42 Sales of Vitamins and Dietary Supplements by Subsector: Value 2001-2006
Table 43 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2001-2006
Table 44 Sales of Vitamins by Type: Value 2001-2006
Table 45 Sales of Vitamins by Type: % Value Growth 2001-2006
Table 46 Vitamins and Dietary Supplements Company Shares by Retail Value 2002-2006
Table 47 Vitamins and Dietary Supplements Brand Shares by Retail Value 2003-2006
Table 48 Vitamins Brand Shares by Retail Value 2003-2006
Table 49 Sales of Dietary Supplements by Type: Value 2001-2006
Table 50 Sales of Dietary Supplements by Type: % Value Growth 2001-2006
Table 51 Dietary Supplements Brand Shares by Retail Value 2003-2006
Table 52 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2006-2011
Table 53 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2006-2011
EYE CARE
Overview
Sector Data
Table 54 Sales of Eye Care by Subsector: Value 2001-2006
Table 55 Sales of Eye Care by Subsector: % Value Growth 2001-2006
Table 56 Eye Care Company Shares by Retail Value 2002-2006
Table 57 Eye Care Brand Shares by Retail Value 2003-2006
Table 58 Forecast Sales of Eye Care by Subsector: Value 2006-2011
Table 59 Forecast Sales of Eye Care by Subsector: % Value Growth 2006-2011
WOUND TREATMENTS
Overview
Sector Data
Table 60 Sales of Wound Treatments by Subsector: Value 2001-2006
Table 61 Sales of Wound Treatments by Subsector: % Value Growth 2001-2006
Table 62 Wound Treatments Company Shares by Retail Value 2002-2006
Table 63 Wound Treatments Brand Shares by Retail Value 2003-2006
Table 64 Forecast Sales of Wound Treatments by Subsector: Value 2006-2011
Table 65 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2006-2011
EAR CARE
ADULT MOUTH CARE
CALMING AND SLEEPING PRODUCTS
DROGUERÍA INTI SA
Strategic Direction
Key Facts
Summary 2 Droguería INTI SA: Key Facts
Summary 3 Droguería INTI SA: Operational Indicators 2004-2006
Company Background
Production
Competitive Positioning
Summary 4 Droguería INTI SA: Competitive Position 2006
LABORATORIOS CRESPAL SA
Strategic Direction
Key Facts
Summary 5 Laboratorios Crespal SA: Key Facts
Summary 6 Laboratorios Crespal SA: Operational Indicators 2004-2006
Company Background
Production
Competitive Positioning
Summary 7 Laboratorios Crespal SA: Competitive Position 2006